Pharma-Bio Serv Approves Special Dividend for ShareholdersOn January 29, 2025, Pharma-Bio Serv, Inc. released a statement detailing the approval of a Special Dividend for its shareholders. The company, a regulatory affairs and consulting firm caterin

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Pharma-Bio Serv’s 8K filing here.

About Pharma-Bio Serv

(Get Free Report)

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.

See Also